Related Experiment Video
Updated: Jun 8, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Anti-HCV prevalence among diabetic and non-diabetic Egyptian children
H El-Karaksy1, G H Anwar, M S El-Raziky
1Department of Pediatrics, Cairo University, Cairo, Egypt.
Insights
Hepatitis C virus (HCV) infection prevalence was similar in children with type 1 diabetes and non-diabetic children. Standard infection control measures can prevent HCV spread in pediatric diabetes units, even in high-prevalence areas like Egypt.
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Hepatology
Background:
- Type 1 diabetes (T1DM) management involves frequent medical interventions, raising concerns about potential infection transmission.
- Hepatitis C virus (HCV) is a significant public health concern, particularly in Egypt, a country with a high HCV burden.
Purpose of the Study:
- To determine the prevalence of HCV infection in children with T1DM compared to non-diabetic children.
- To investigate potential risk factors for HCV infection in these pediatric populations.
Main Methods:
- A comparative study involving 692 children with T1DM and 1042 non-diabetic children from Cairo University Pediatric Hospital.
- Screening for anti-HCV antibodies using third-generation ELISA.
- Assessment of exposure to medical care, personal hygiene practices, and environmental factors.
Main Results:
- Anti-HCV antibody prevalence was comparable between diabetic (2.5%) and non-diabetic (1.4%) children below 9 years of age (p=0.25).
- Children with T1DM showed higher exposure to medical care, including daily insulin injections and blood glucose monitoring (p=0.04).
- Non-diabetic children reported higher exposure to shared razors (p=0.05) and traditional haircutting practices (p=0.05).
Conclusions:
- HCV prevalence is similar in young children with and without type 1 diabetes.
- Implementing standard infection control precautions is effective in preventing HCV transmission within pediatric diabetes units.
- The findings underscore the importance of infection control in managing T1DM in high HCV prevalence settings.
Abstract:
Our aim was to determine the prevalence of the HCV infection among children with type 1 DM as compared to a group of non-diabetic children attending the general outpatient clinics of the same hospital and investigate the possible risk factors. The study was carried out on 692 children with type 1 DM attending the Pediatric Diabetes Unit at Cairo University Pediatric Hospital, Egypt, and 1042 non-diabetic children attending the general outpatient clinics of the same hospital. They were screened for HCV antibodies using third generation ELISA. Anti-HCV antibody prevalence in diabetic children below 9 years of age was comparable to that of non diabetic children (2.5% vs. 1.4%; p=0.25). Diabetic children had higher exposure to medical care (p=0.04); all diabetics were exposed to daily insulin injections and daily blood glucose monitoring. Non-diabetics had higher exposure to razors used by others (p=0.05) and higher rate of traditional hair cutting (p=0.05). To conclude, the prevalence of anti-HCV in diabetic children below 9 years of age was comparable to non diabetic children of the same age group. Application of standard precautions for infection control could successfully limit spread of HCV infection in our Pediatric Diabetes Unit, in a country with high HCV load as Egypt.
Related Concept Videos
Hepatitis
Cytomegalovirus Disease
Viral Hepatitis I: Introduction
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
